Tauroursodeoxycholic Acid Combined With PD-1/PD-L1 Immunotherapy in Advanced Hepatocellular Carcinoma: A Prospective Study
Clinical trial NCT07064668 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07064668
- Sponsor
- Tongji Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-30
- Primary completion
- 2027-06-30
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.